[Abstract] Objective: To investigate the effects of salidroside on the proliferation, invasion and apoptosis of cervical squamous cell carcinoma C33A cells and explore its possible mechanism. Methods: C33A cells were divided into 4 groups: control group, low-dose group (salidroside 50 μg/mL), high-dose group (salidroside 150 μg/mL), and AG490 group (inhibitor of JAK2/STAT3 signaling pathway, 50 μmol/L). Effects of salidroside and AG490 on the proliferation, invasion and apoptosis of C33A cells were detected by MTT method, EdU labeling experiment, Transwell assay, Rh123 staining and Flow cytometry, respectively. Western blotting was used to detect the effects of salidroside and AG490 on the expressions of JAK2/STAT3 pathway-related proteins (p-JAK2, p-STAT3) and apoptosis-related proteins (Bax, Bcl-2, caspase-3) in C33A cells. Result: Compared with the control group, the proliferation and DNA synthesis as well as the invasion of C33Acells in the low-dose group were significantly inhibited (all P<0.05), while the apoptosis was significantly enhanced (P<0.05); in the meanwhile, the fluorescence intensity of Rh123 was significantly reduced (all P<0.05) and the membrane structure of C33A cells were destroyed; moreover, the expressions of p-JAK2, p-STAT3 and Bcl-2 were significantly decreased while the expressions of Bax and caspase-3 were significantly increased (all P<0.05). Compared with the low-dose group, the effects of high-dose salidroside and AG490 on the proliferation, invasion, apoptosis and related protein expressions in C33A cells were more significant (all P<0.05), but there was no difference between the high-dose group and the AG490 group. Conclusion: Salidroside can inhibit the proliferation and invasion of C33A cells and promote cell apoptosis. Its mechanism may be related to inhibition of JAK2/ STAT3 signaling pathway.

Autoimmune disease is a chronic inflammatory disease in which the body produces immune response to its own antigen, leading to tissue damage. Autoimmune abnormalities can affect women's fertility and pregnancy outcomes. Pregnancy can also affect the condition of autoimmune diseases. Therefore, it is very important to control disease status before pregnancy, during pregnancy and after childbirth. Tumor necrosis factor-α (TNF-α) plays an important role in the pathogenesis and progress of various autoimmune diseases. TNF-α inhibitors have been used in the treatment of autoimmune diseases. This article reviews the clinical application of TNF-α inhibitors in pregnancy with autoimmune diseases.

Autoimmune disease is a chronic inflammatory disease in which the body produces immune response to its own antigen, leading to tissue damage. Autoimmune abnormalities can affect women's fertility and pregnancy outcomes. Pregnancy can also affect the condition of autoimmune diseases. Therefore, it is very important to control disease status before pregnancy, during pregnancy and after childbirth. Tumor necrosis factor-α (TNF-α) plays an important role in the pathogenesis and progress of various autoimmune diseases. TNF-α inhibitors have been used in the treatment of autoimmune diseases. This article reviews the clinical application of TNF-α inhibitors in pregnancy with autoimmune diseases.